Koen Wullus

Part of The Goldman Sachs Group, Inc., Goldman Sachs Asset Management BV is a Dutch global asset management company. The company is based in The Hague, Netherlands. The company's mission is to help clients achieve their investment goals. The CEOs of the company are Martijn C. M. Canisius, Gerald Cartigny.

Van Lanschot Kempen Investment Management NV (Van Lanschot Kempen) is a specialist wealth manager headquartered in Amsterdam, Netherlands. The firm was founded in 1991 and was formerly known as Kempen Capital Management NV. They are a wholly-owned subsidiary of Van Lanschot Kempen NV (AMS: VLK). Van Lanschot Kempen administers Dutch pension funds and provides integral asset management for Dutch institutional clients.

ING Investment Management (Belgium) (INGIM-BE) is a wholly-owned subsidiary of ING Belgique SA, ultimately part of Netherlands-based ING Groep NV (NYSE: ING). The firm is located in Brussels. INGIM-BE provides a combination of retail and private banking financial services. The firm is the local distributor for the group's diverse range of investment products, and also distributes the Belgium- and Luxembourg-domiciled funds globally. In Europe the investment management center is in the Netherlands.

AEGON Investment Management BV (Netherlands) (AEGON-IM) is the wholly-owned investment management subsidiary of AEGON Asset Management Holding BV, itself a subsidiary of AEGON NV (XA: AGN, ADR: AEG), the Netherlands-based life insurance group. Established in 1968, originally focusing their activity in the Netherlands, the US and Great Britain, the firm is located in The Hague and is a fixed-income specialist which manages pension funds for institutional investors.

M&G Investment Management Ltd. (MAGIM) is the asset management subsidiary of MG FA Ltd., ultimately owned by M&G Plc (LON: MNG) in Great Britain. Formerly known as Prudential Investment Management Ltd., the firm was founded in 1968 and is headquartered in London. MAGIM provides investment management for a broad range of clients, with a product range that includes segregated mandates for institutions as well as retail mutual funds for individuals.

Edenspiekermann BV provides design consulting services. The private company is based in Amsterdam, Netherlands and has subsidiaries in Germany. The Dutch company was founded by Erik Spiekermann. Vanessa Flink has been the CEO of the company since 2022.

Whyz BV provides executive search and interim management services. The private company is based in Leiden, Netherlands. The Dutch company was founded in 2010 by Marty Tuk, Pieter Riedstra.

APG DWS en Fondsenbedrijf NV engages in the provision of financial services. It offers executive consultancy, asset management, and pension administration and communication. The company is headquartered in Heerlen, the Netherlands.

APG Group NV provides financial services. It offers pension fund administration, communication, asset management, and management support and services to pension funds. The company was founded on February 29, 2008 and is headquartered in Heerlen, the Netherlands.

Capital International, Inc. (Investment Management Singapore) (Capital IM-SG) is the investment management division of Capital International, Inc., itself a subsidiary of The Capital Group Cos., Inc. in the US, a privately-owned holding company established in 1931 by Jonathan Bell Lovelace which specializes in global investment management for corporations, private individuals, foundations and endowments. Capital IM-SG is headquartered in Singapore and was founded in 1989. They are an autonomous regional investment team which shares research with the Capital Group's affiliates through centralized databases.

Mimix Biotherapeutics Sàrl is a private company located in Switzerland that develops and commercializes a platform to overcome limitations in tissue engineering, specifically the vascularization challenge and the need for high cell quantities. The Swiss company creates biological architectures with sound using sound-induced morphogenesis, which is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. The company offers guides for patterning parameters and cells in various hydrogels, including collagen, fibrin, gelatine, and synthetic hydrogels. The company's FastSkin® technology combines micrografting with sound-induced morphogenesis to improve wound care management, addressing a major social burden and unmet clinical need in oncology and chronic wounds treatments. Mimix Biotherapeutics also provides control over cellular and extracellular organization at high spatial resolution to investigate cell-material interactions in vitro models.